These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26932576)

  • 41. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
    Carlsson R; Persson C; Leanderson T
    Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells.
    Kubosaki A; Lindgren G; Tagami M; Simon C; Tomaru Y; Miura H; Suzuki T; Arner E; Forrest AR; Irvine KM; Schroder K; Hasegawa Y; Kanamori-Katayama M; Rehli M; Hume DA; Kawai J; Suzuki M; Suzuki H; Hayashizaki Y
    Mol Immunol; 2010 Aug; 47(14):2295-302. PubMed ID: 20573402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines.
    Ahyi AN; Chang HC; Dent AL; Nutt SL; Kaplan MH
    J Immunol; 2009 Aug; 183(3):1598-606. PubMed ID: 19592658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.
    Ma S; Pathak S; Trinh L; Lu R
    Blood; 2008 Feb; 111(3):1396-403. PubMed ID: 17971486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct regulatory networks control the development of macrophages of different origins in zebrafish.
    Yu T; Guo W; Tian Y; Xu J; Chen J; Li L; Wen Z
    Blood; 2017 Jan; 129(4):509-519. PubMed ID: 27940477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
    Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
    Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IRF8-dependent molecular complexes control the Th9 transcriptional program.
    Humblin E; Thibaudin M; Chalmin F; Derangère V; Limagne E; Richard C; Flavell RA; Chevrier S; Ladoire S; Berger H; Boidot R; Apetoh L; Végran F; Ghiringhelli F
    Nat Commun; 2017 Dec; 8(1):2085. PubMed ID: 29233972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks.
    Chopin M; Seillet C; Chevrier S; Wu L; Wang H; Morse HC; Belz GT; Nutt SL
    J Exp Med; 2013 Dec; 210(13):2967-80. PubMed ID: 24249112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
    Marecki S; Riendeau CJ; Liang MD; Fenton MJ
    J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IRF-4 functions as a tumor suppressor in early B-cell development.
    Acquaviva J; Chen X; Ren R
    Blood; 2008 Nov; 112(9):3798-806. PubMed ID: 18713947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
    Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
    Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.
    Ochiai K; Maienschein-Cline M; Simonetti G; Chen J; Rosenthal R; Brink R; Chong AS; Klein U; Dinner AR; Singh H; Sciammas R
    Immunity; 2013 May; 38(5):918-29. PubMed ID: 23684984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
    Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
    Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The development of functional B lymphocytes in conditional PU.1 knock-out mice.
    Polli M; Dakic A; Light A; Wu L; Tarlinton DM; Nutt SL
    Blood; 2005 Sep; 106(6):2083-90. PubMed ID: 15933053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional mechanism of IRF8 and PU.1 governs microglial activation in neurodegenerative condition.
    Zhou N; Liu K; Sun Y; Cao Y; Yang J
    Protein Cell; 2019 Feb; 10(2):87-103. PubMed ID: 30484118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual Roles of PU.1 in the Expression of PD-L2: Direct Transactivation with IRF4 and Indirect Epigenetic Regulation.
    Inaba K; Yashiro T; Hiroki I; Watanabe R; Kasakura K; Nishiyama C
    J Immunol; 2020 Aug; 205(3):822-829. PubMed ID: 32611724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PU.1 opposes IL-7-dependent proliferation of developing B cells with involvement of the direct target gene bruton tyrosine kinase.
    Christie DA; Xu LS; Turkistany SA; Solomon LA; Li SK; Yim E; Welch I; Bell GI; Hess DA; DeKoter RP
    J Immunol; 2015 Jan; 194(2):595-605. PubMed ID: 25505273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development.
    Ma S; Turetsky A; Trinh L; Lu R
    J Immunol; 2006 Dec; 177(11):7898-904. PubMed ID: 17114461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.
    Batista CR; Lim M; Laramée AS; Abu-Sardanah F; Xu LS; Hossain R; Bell GI; Hess DA; DeKoter RP
    Blood Adv; 2018 Nov; 2(21):2798-2810. PubMed ID: 30355579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.